News room
Technophage was recognized with ‘PME líder 2023’ distinction by IAPMEI
We are thrilled to announce that Technophage has been recognized by IAPMEI, I.P. - Agência para a Competitividade e Inovação (Agency for...
Technophage honored with a Healthcare & Pharmaceutical Award
For eight years in a row, the Healthcare & Pharmaceutical Awards have recognized the pioneers transforming our healthcare field. We are thrilled...
TZ-161 one step closer to clinical trials in spinal cord injury
Technophage is thrilled to share that TZ-161 product is now one step closer to potentially becoming a pioneering repurposed treatment for patients...
Miguel Garcia unveils plans for the Bio-Hub Agenda at the First Annual Meeting
Miguel Garcia, the CEO of Technophage S.A. and LxBio - Pharmaceuticals S.A., recently presented the Bio-Hub Project during the First Annual Meeting...
Annual Teambuilding event celebrated in the picturesque town of Dornes
This week marked an important occasion as Technophage and VectorB2B - Drug Development joined forces for our annual Teambuilding event. Our...